NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
ASGCT encourages authors to make their work more accessible to the broad CGT community by including plain language summaries.
Make your timely research findings more accessible to the rare disease community by submitting a summary using plain language. Submissions of the plain language summary will not be used in the review for abstract acceptance. These summaries will instead be reviewed by the Patient Outreach Committee, and the top ones will be highlighted and shared alongside accepted abstracts. All plain language summaries will be under the same embargo policy as the abstracts.
There are many useful resources online to assist with writing a Plain Language Summary:
Plain language summaries will be reviewed by taking into consideration the following criteria:
All summaries submitted will be reviewed by the ASGCT Patient Outreach Committee for final consideration in the abstract publication.
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico